Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Biocryst Pharma Inc (BCRX)

Biocryst Pharma Inc (BCRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,983,551
  • Shares Outstanding, K 186,424
  • Annual Sales, $ 157,170 K
  • Annual Income, $ -184,060 K
  • 60-Month Beta 1.97
  • Price/Sales 8.27
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BCRX with:

Options Overview Details

View History
  • Implied Volatility 53.45% ( -0.90%)
  • Historical Volatility 49.03%
  • IV Percentile 3%
  • IV Rank 7.35%
  • IV High 96.88% on 05/11/22
  • IV Low 50.00% on 12/23/22
  • Put/Call Vol Ratio 0.03
  • Today's Volume 419
  • Volume Avg (30-Day) 2,668
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 68,947
  • Open Int (30-Day) 88,214

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.19
  • Number of Estimates 6
  • High Estimate 0.16
  • Low Estimate -0.45
  • Prior Year -0.40
  • Growth Rate Est. (year over year) +52.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.55 +11.83%
on 01/09/23
11.36 -5.99%
on 01/09/23
-1.14 (-9.64%)
since 01/06/23
3-Month
9.55 +11.83%
on 01/09/23
14.20 -24.79%
on 11/15/22
-1.15 (-9.72%)
since 11/07/22
52-Week
7.61 +40.34%
on 05/12/22
19.99 -46.57%
on 02/16/22
-5.70 (-34.80%)
since 02/07/22

Most Recent Stories

More News
Neurocrine Biosciences (NBIX) Lags Q4 Earnings Estimates

Neurocrine (NBIX) delivered earnings and revenue surprises of -23.48% and 0.21%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

NBIX : 103.82 (-1.14%)
BCRX : 10.68 (+0.38%)
Wall Street Analysts Predict a 48% Upside in BioCryst (BCRX): Here's What You Should Know

The mean of analysts' price targets for BioCryst (BCRX) points to a 47.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts...

BCRX : 10.68 (+0.38%)
BioCryst (BCRX) Down as it Discontinues Developing PNH Drug

BioCryst (BCRX) down as it drops the development of BCX9930, which was being evaluated for PNH.

BCRX : 10.68 (+0.38%)
GILD : 86.05 (-0.36%)
VTGN : 0.2608 (+4.53%)
VIR : 29.45 (-1.17%)
BioCryst Pharmaceuticals (BCRX) Q3 2022 Earnings Call Transcript

BCRX earnings call for the period ending September 30, 2022.

BCRX : 10.68 (+0.38%)
BioCryst Pharmaceuticals (BCRX) Reports Q3 Loss, Tops Revenue Estimates

BioCryst (BCRX) delivered earnings and revenue surprises of 28.13% and 3.23%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

BCRX : 10.68 (+0.38%)
MKGAF : 195.0000 (-1.76%)
Theravance Biopharma (TBPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Theravance Bio (TBPH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TBPH : 10.60 (-0.19%)
BCRX : 10.68 (+0.38%)
Will BioCryst Pharmaceuticals (BCRX) Report Negative Earnings Next Week? What You Should Know

BioCryst (BCRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BCRX : 10.68 (+0.38%)
Got $3,000? Here Are 2 Stocks That Will Make You Richer

BioCryst Pharmaceuticals and Steris could both deliver outstanding returns for patient shareholders.

BCRX : 10.68 (+0.38%)
STE : 217.01 (+1.10%)
Has Alignment Healthcare (ALHC) Outpaced Other Medical Stocks This Year?

Here is how Alignment Healthcare (ALHC) and BioCryst Pharmaceuticals (BCRX) have performed compared to their sector so far this year.

ALHC : 11.42 (+2.42%)
BCRX : 10.68 (+0.38%)
BioCryst Pharmaceuticals (BCRX) Q2 2022 Earnings Call Transcript

BCRX earnings call for the period ending June 30, 2022.

BCRX : 10.68 (+0.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential...

See More

Key Turning Points

3rd Resistance Point 11.15
2nd Resistance Point 10.94
1st Resistance Point 10.81
Last Price 10.68
1st Support Level 10.48
2nd Support Level 10.27
3rd Support Level 10.14

See More

52-Week High 19.99
Fibonacci 61.8% 15.26
Fibonacci 50% 13.80
Fibonacci 38.2% 12.34
Last Price 10.68
52-Week Low 7.61

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar